Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rachel Styles"'
Autor:
Rachel Sanborn, Nashat Gabrail, Benedito Carneiro, Mark O'Hara, Rodolfo Bordoni, Michael Gordon, Danny Khalil, Ralph Hauke, Cherie Taglienti, Mark Rogalski, Rachel Styles, Diego Alvarado, Deena Maurer, Linda Crew, Tibor Keler, Michael Yellin
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Omar Nadeem, Robert Redd, Laura V. Stampleman, Jeffrey V. Matous, Andrew J. Yee, Jeffrey A. Zonder, Andrew Kin, Jacalyn Rosenblatt, Mark Bustoros, MD, Julia Prescott, Alexandra Savell, Kathleen Guimond, Erin Frey, Rachel Styles, Adrienne Bielawski, Cody J Boehner, Nang Kham Su, Multiple Myeloma Research Foundation Multiple Myeloma Research Foundation, The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society, BCRP Blood Cancer Research Partnership, Adam S Sperling, Giada Bianchi, Jacob P. Laubach, Jorge J. Castillo, Nikhil C. Munshi, Kenneth C. Anderson, Paul G. Richardson, Lorenzo Trippa, Irene M. Ghobrial
Publikováno v:
Blood. 134:1898-1898
Introduction: Daratumumab (DARA) is an anti-CD38 monoclonal antibody that is approved for use in patients with newly diagnosed and relapsed multiple myeloma (MM). We hypothesized that early therapeutic intervention with DARA in patients with high-ris
Autor:
Irene M. Ghobrial, Gabriela S. Hobbs, Valentina Nardi, David J. Kuter, Annemarie E. Fogerty, Nicholas A. Jessop, Donna Neuberg, Nathan T. Connell, Chi-Joan How, Jennifer Lombardi Story, Nancy Higgins, Jean M. Connors, Orly Leiva, Geoffrey Fell, Jeffrey I. Zwicker, Thomas Bogue, Ann Mullally, Rachel Styles, Mark Bustoros
Publikováno v:
Blood. 134:4172-4172
BACKGROUND: Myeloproliferative neoplasms (MPNs) including essential thrombocythemia (ET) and polycythemia vera (PV) are commonly diagnosed in the sixth decade, but as many as 20% of patients are younger than 40. This introduces the possibility of pre
Autor:
Irene M. Ghobrial, Paul G. Richardson, Kenneth C. Anderson, Jacob P. Laubach, Nikhil C. Munshi, Diane Warren, Houry Leblebjian, Kaitlen Reyes, Cody J Boehner, Govind Bindra, Nang Kham Su, Alexandra Savell, Kalvis Hornburg, Rachel Styles, Kathleen Guimond, Erin Frey, Julia Prescott, Robert A. Redd, Lily Ardente, Giada Bianchi, Adam S Sperling, Omar Nadeem, Mark Bustoros, MD
Publikováno v:
Blood. 134:580-580
Background.This study aimed to determine the progression-free survival and response rate using early therapeutic intervention in patients with high-risk smoldering multiple myeloma (SMM) using the combination of ixazomib, lenalidomide, and dexamethas
Autor:
Mark Bustoros, Chia-jen Liu, Kaitlen Reyes, Kalvis Hornburg, Kathleen Guimond, Rachel Styles, Alexandra Savell, Brianna Berrios, Diane Warren, Henry Dumke, Bradley Rivotto, Patrick Henrick, Emily Scranton, Houry Leblebjian, Kirsten Meid, Robert L. Schlossman, Nikhil Munshi, Jacob Laubach, Kenneth C. Anderson, Paul Richardson, Irene M. Ghobrial
Publikováno v:
Blood. 132:804-804
Background. This study aimed to determine the progression-free survival and response rate using early therapeutic intervention in patients with high-risk smoldering multiple myeloma (SMM) using the combination of ixazomib, lenalidomide, and dexametha